| Patent | Date |
|---|
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
Grant 11,358,954 - Lagu , et al. June 14, 2 | 2022-06-14 |
Hmox1 Inducers
App 20220177460 - Biddle; Margaret ; et al. | 2022-06-09 |
Poly-adp Ribose Polymerase (parp) Inhibitors
App 20220033380 - Takahashi; Taisuke ; et al. | 2022-02-03 |
Methods Of Treating Acute Kidney Injury
App 20210283116 - Lagu; Bharat ; et al. | 2021-09-16 |
Pyrrolopyrimidine Compounds And Their Uses
App 20210253578 - BESONG; Gilbert ; et al. | 2021-08-19 |
Ppar Agonists, Compounds, Pharmaceutical Compositions, And Methods Of Use Thereof
App 20210253549 - Downes; Michael ; et al. | 2021-08-19 |
Poly-ADP ribose polymerase (PARP) inhibitors
Grant 11,034,670 - Takahashi , et al. June 15, 2 | 2021-06-15 |
Crystalline And Salt Forms Of Ppar Agonist Compounds
App 20210171494 - Lagu; Bharat ; et al. | 2021-06-10 |
USP30 inhibitors
Grant 10,968,172 - Kluge , et al. April 6, 2 | 2021-04-06 |
Crystalline and salt forms of PPAR agonist compounds
Grant 10,927,094 - Lagu , et al. February 23, 2 | 2021-02-23 |
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
Grant 10,906,885 - Downes , et al. February 2, 2 | 2021-02-02 |
Ppar Agonists, Compounds, Pharmaceutical Compositions, And Methods Of Use Thereof
App 20200347037 - LAGU; Bharat ; et al. | 2020-11-05 |
HMOX1 inducers
Grant 10,766,888 - Biddle , et al. Sep | 2020-09-08 |
Crystalline And Salt Forms Of Ppar Agonist Compounds
App 20200181108 - Lagu; Bharat ; et al. | 2020-06-11 |
Ppar Agonists, Compounds, Pharmaceutical Compositions, And Methods Of Use Thereof
App 20200157074 - Downes; Michael ; et al. | 2020-05-21 |
Usp30 Inhibitors
App 20200131121 - Kluge; Arthur ; et al. | 2020-04-30 |
Poly-adp Ribose Polymerase (parp) Inhibitors
App 20200071299 - Takahashi; Taisuke ; et al. | 2020-03-05 |
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
Grant 10,479,775 - Downes , et al. Nov | 2019-11-19 |
Ppar Agonists, Compounds, Pharmaceutical Compositions, And Methods Of Use Thereof
App 20190337920 - Downes; Michael ; et al. | 2019-11-07 |
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
Grant 10,399,958 - Downes , et al. Sep | 2019-09-03 |
Ppar Agonists, Compounds, Pharmaceutical Compositions, And Methods Of Use Thereof
App 20190084958 - Downes; Michael ; et al. | 2019-03-21 |
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
Grant 10,188,627 - Downes , et al. Ja | 2019-01-29 |
Pyrrolopyrimidine Compounds And Their Uses
App 20180155351 - Besong; Gilbert ; et al. | 2018-06-07 |
Ppar Agonists, Compounds, Pharmaceutical Compositions, And Methods Of Use Thereof
App 20170305894 - Baiga; Thomas ; et al. | 2017-10-26 |
Ppar Agonists, Compounds, Pharmaceutical Compositions, And Methods Of Use Thereof
App 20170304255 - Baiga; Thomas ; et al. | 2017-10-26 |
Pyrrolopyrimidine Compounds And Their Uses
App 20170183352 - BESONG; Gilbert ; et al. | 2017-06-29 |
Pyrrolopyrimidine compounds and their uses
Grant 9,416,136 - Besong , et al. August 16, 2 | 2016-08-16 |
Pyridazinyl derivatives as SMO inhibitors
Grant 9,409,871 - He , et al. August 9, 2 | 2016-08-09 |
Pyrrolopyrimidine compounds as inhibitors of CDK4/6
Grant 9,309,252 - Brain , et al. April 12, 2 | 2016-04-12 |
Tricyclic Sulfonamide Derivatives
App 20150183802 - CHEN; Shuhui ; et al. | 2015-07-02 |
Pyrazoline derivatives and their use as selective androgen receptor modulators
Grant 9,051,326 - Bock , et al. June 9, 2 | 2015-06-09 |
Pyrrolopyrimidine Compounds As Inhibitors Of Cdk4/6
App 20150099737 - BRAIN; Christopher Thomas ; et al. | 2015-04-09 |
Pyrrolopyrimidine compounds and their uses
Grant 8,962,630 - Brain , et al. February 24, 2 | 2015-02-24 |
Pyrrolopyrimidine compounds as inhibitors of CDK4/6
Grant 8,957,074 - Brain , et al. February 17, 2 | 2015-02-17 |
Pyrazoline Derivatives And Their Use As Selective Androgen Receptor Modulators
App 20140329876 - Bock; Mark Gary ; et al. | 2014-11-06 |
Cyclic Urea Derivatives As Androgen Receptor Antagonists
App 20140329858 - Bock; Mark Gary ; et al. | 2014-11-06 |
Pyrrolopyrimidine Compounds And Their Uses
App 20140135312 - BESONG; Gilbert ; et al. | 2014-05-15 |
Pyrrolopyrimidine compounds and their uses
Grant 8,685,980 - Besong , et al. April 1, 2 | 2014-04-01 |
Imidazole derivatives and their use as modulators of cyclin dependent kinases
Grant 8,598,217 - Howard , et al. December 3, 2 | 2013-12-03 |
Pyridazinyl Derivatives As Smo Inhibitors
App 20130261299 - He; Feng ; et al. | 2013-10-03 |
Pyrrolopyrimidine Compounds And Their Uses
App 20130184285 - BRAIN; Christopher Thomas ; et al. | 2013-07-18 |
Pyridazinyl derivatives as smo inhibitors
Grant 8,481,542 - He , et al. July 9, 2 | 2013-07-09 |
Pyrrolopyrimidine Compounds As Inhibitors Of Cdk4/6
App 20130150342 - Brain; Christopher Thomas ; et al. | 2013-06-13 |
Pyrrolopyrimidine compounds and their uses
Grant 8,415,355 - Brain , et al. April 9, 2 | 2013-04-09 |
Organic Compounds As Smo Inhibitors
App 20120289507 - HE; Feng ; et al. | 2012-11-15 |
Dihydro-[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
Grant 8,236,819 - Lagu , et al. August 7, 2 | 2012-08-07 |
Imidazole Derivatives And Their Use As Modulators Of Cyclin Dependent Kinases
App 20120101064 - Howard; Steven ; et al. | 2012-04-26 |
Quaternary salt CCR2 antagonists
Grant 7,799,824 - Lagu , et al. September 21, 2 | 2010-09-21 |
Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
Grant 7,723,326 - Lagu , et al. May 25, 2 | 2010-05-25 |
Dihydro-[1h]-quinolin-2-one Derivatives As Rxr Agonists For The Treatment Of Dyslipidemia, Hypercholesterolemia And Diabetes
App 20100105728 - Lagu; Bharat ; et al. | 2010-04-29 |
Organic Compounds as Smo Inhibitors
App 20100041663 - HE; Feng ; et al. | 2010-02-18 |
Dihydro-1[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
Grant 7,638,533 - Lagu , et al. December 29, 2 | 2009-12-29 |
Tetrahydro-indazole Cannabinoid Modulators
App 20090099143 - Lagu; Bharat ; et al. | 2009-04-16 |
Substituted Thiatriazaacenaphthylene-6-carbonitrile Kinase Inhibitors
App 20080300264 - Connolly; Peter J. ; et al. | 2008-12-04 |
Tetrahydro-indazole cannabinoid modulators
Grant 7,452,997 - Lagu , et al. November 18, 2 | 2008-11-18 |
Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
Grant 7,427,625 - Connolly , et al. September 23, 2 | 2008-09-23 |
Matrix Metalloprotease Inhibitors
App 20080085893 - YANG; Shyh-Ming ; et al. | 2008-04-10 |
Substituted Thiatriazaacenaphthylene-6-carbonitrile Kinase Inhibitors
App 20070225309 - Connolly; Peter J. ; et al. | 2007-09-27 |
Phospholipase C inhibitors for use in treating inflammatory disorders
Grant 7,262,197 - Lagu , et al. August 28, 2 | 2007-08-28 |
Dihydro-[1h]-quinolin-2-one Derivatives As Rxr Agonists For The Treatment Of Dyslipidemia, Hypercholesterolemia And Diabetes
App 20070078160 - Lagu; Bharat ; et al. | 2007-04-05 |
Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
App 20070078129 - Lagu; Bharat ; et al. | 2007-04-05 |
Quaternary salt CCR2 antagonists
App 20060293379 - Lagu; Bharat ; et al. | 2006-12-28 |
Tetrahydro-indazole cannabinoid modulators
App 20050228034 - Lagu, Bharat ; et al. | 2005-10-13 |
Phospholipase C inhibitors for use in treating inflammatory disorders
App 20040242639 - Lagu, Bharat ; et al. | 2004-12-02 |
Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
App 20040242609 - Marzabadi, Mohammad R. ; et al. | 2004-12-02 |
Phospholipase C inhibitors for use in treating inflammatory disorders
App 20040235827 - Lagu, Bharat ; et al. | 2004-11-25 |
Phospholipase C inhibitors for use in treating inflammatory disorders
App 20040235855 - Lagu, Bharat ; et al. | 2004-11-25 |
Dihydropyrimidines and uses thereof
App 20040138242 - Cui, Donghui ; et al. | 2004-07-15 |
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
Grant 6,727,257 - Nagarathnam , et al. April 27, 2 | 2004-04-27 |
Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
Grant 6,720,324 - Marzabadi , et al. April 13, 2 | 2004-04-13 |
Dihydropyrimidines and uses thereof
Grant 6,680,323 - Cui , et al. January 20, 2 | 2004-01-20 |
Morpholinone and morpholine derivatives and uses thereof
App 20030212062 - Lagu, Bharat ; et al. | 2003-11-13 |
Oxazolidinones and uses thereof
Grant 6,620,815 - Lagu , et al. September 16, 2 | 2003-09-16 |
Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
App 20030069261 - Marzabadi, Mohammad R. ; et al. | 2003-04-10 |
Morpholinone and morpholine derivatives and uses thereof
App 20020068737 - Lagu, Bharat ; et al. | 2002-06-06 |
Dihydropyrimidines and uses thereof
App 20020010186 - Wong, Wai C. ; et al. | 2002-01-24 |
Dihydropyrimidines and uses thereof
App 20010041707 - Cui, Donghui ; et al. | 2001-11-15 |
Dihydropyrimidines and uses thereof
Grant 6,274,585 - Cui , et al. August 14, 2 | 2001-08-14 |
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
Grant 6,268,369 - Nagarathnam , et al. July 31, 2 | 2001-07-31 |
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
Grant 6,245,773 - Wong , et al. June 12, 2 | 2001-06-12 |
Morpholinone and morpholine derivatives and uses thereof
Grant 6,218,390 - Lagu , et al. April 17, 2 | 2001-04-17 |
Oxazolidinones as .alpha..sub.1A receptor antagonists
Grant 6,159,990 - Lagu , et al. December 12, 2 | 2000-12-12 |
| 